Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Bacil Pharma Ltd
Your Vote -
Buy
50.00%
Hold
33.33%
Sell
16.67%
50.00%
6 users have voted
Option Chain
Analyzes market sentiment, predicts Bacil Pharma Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Bacil Pharma - Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Company Is Sc
-
Bacil Pharma has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025
-
Bacil Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Bacil Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Bacil Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Bacil Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Bacil Pharma - INTIMATION OF RECEIPT OF REQUEST FOR RECLASSIFICATION OF THE 'PROMOTER' IN ACCORDANCE WITH REGULATION 31A OF T
-
Bacil Pharma - Board Meeting Intimation for We Hereby Notify You That A Meeting Of The Board Of Directors Of Bacil Pharma Lim
-
Bacil Pharma - Board Meeting Outcome for Revised Outcome Of Board Meeting Held On 25Th August 2025
-
Bacil Pharma - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
-
Bacil Pharma - Board Meeting Outcome for Revised Outcome Of Board Meeting Held On 25Th August 2025
-
Bacil Pharma - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
-
Bacil Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th August 2025
-
Bacil Pharma - Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Company Is Sc
-
Bacil Pharma - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
-
Bacil Pharma - Results Financial Results For The Quarter Ended 30/06/2025
-
Bacil Pharma - Board Meeting Outcome for Results For The Quarter Ended 30/06/2025
Key fundamentals
Evaluate the intrinsic value of Bacil Pharma Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 25.5952 | 1.3117 | 1.12 | 1.2575 | 1.5669 |
| Liabilities | 25.5952 | 1.3117 | 1.12 | 1.2575 | 1.5669 |
| Equity | 13.9702 | 6.5272 | 6.5271 | 6.5271 | 6.5271 |
| Gross Profit | -0.2532 | -0.1875 | -0.2138 | -3.9138 | -0.3086 |
| Net Profit | 0.4041 | -0.0589 | -0.1018 | -3.8598 | -0.2392 |
| Cash From Operating Activities | 0.4008 | -0.0029 | -0.1474 | -4.0089 | -0.398 |
| NPM(%) | 0 | 0 | 0 | 0 | 0 |
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.2532 | 0.1875 | 0.2138 | 3.9138 | 0.3086 |
| ROE(%) | 1.56 | -0.22 | -0.39 | -14.95 | -0.92 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Bacil Pharma Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 851.70 | -2.84 | 77.71 | 16.07 | 301.39 | 0.58 |
| Lotus Eye Hospital and Institute Ltd | 120.75 | -1.23 | 391.06 | 58.56 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 20.25 | -0.10 | 0.00 | 121.59 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 634.95 | -1.26 | 0.00 | 55.23 | -604.77 | 0.00 |
Company Info
Bacil Pharma Ltd as incorporated as a P Ltd company in the State Maharashtra onm 8th May 1987. It has been converted into public Ltd company on 19.9.90 and obtained fresh certificate of incorporation consequent to the change of name on 26.10.93. There has been no business acitivity since incorporation. The main promoter of the company is Mr. Prakash Shah. The company is implementing a project to manufacture Bulk drugs viz, Atenalol, Ciprofloxacin, Pefloxacain, Mesylate, Norfloxacin and Para Hydroxy Phenyl Acetamide. 2008 - Bacil Pharma - E-mail ID for Investor Grievances is bacilpha@yahoo.com.
Bacil Pharma Ltd as incorporated as a P Ltd company in the State Maharashtra onm 8th May 1987. It has been converted into public Ltd company on 19.9.90 and obtained fresh certificate of incorporation consequent to the change of name on 26.10.93. There has been no business acitivity since incorporation. The main promoter of the company is Mr. Prakash Shah. The company is implementing a project to manufacture Bulk drugs viz, Atenalol, Ciprofloxacin, Pefloxacain, Mesylate, Norfloxacin and Para Hydroxy Phenyl Acetamide. 2008 - Bacil Pharma - E-mail ID for Investor Grievances is bacilpha@yahoo.com.
Read More
Parent Organisation
Bacil Pharma Ltd.
Founded
08/05/1987
Managing Director
NSE Symbol
FAQ
The current price of Bacil Pharma Ltd is
The 52-week high for Bacil Pharma Ltd is
The market capitalization of Bacil Pharma Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Bacil Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Bacil Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Bacil Pharma Ltd shares.
The CEO of Bacil Pharma Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
